Barinthus Biotherapeutics plc - stock earnings
Stock symbol VACC is outdated, potentially delisted? Maybe it is available on other exchange?
VACC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -21.2 million USD | 6.5 million USD |
| 2022Q3 | 8.2 million USD | 6.2 million USD |
| 2022Q2 | 15.7 million USD | 17.1 million USD |
| 2022Q1 | 2.6 million USD | 15.0 million USD |
| 2021Q4 | -15.1 million USD | -1000 USD |
| 2021Q3 | -4.6 million USD | 19000 USD |
| 2021Q2 | -15.9 million USD | 35000 USD |
| 2021Q1 | -15.3 million USD | 215000 USD |
| 2020Q3 | 158000 USD | 3.3 million USD |
| 2020Q2 | -3.6 million USD | 511000 USD |
| 2020Q1 | -3.8 million USD | 705000 USD |
VACC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 5.3 million USD | 44.7 million USD |
| 2021 | -50.9 million USD | 268000 USD |
| 2020 | -17.7 million USD | 4.8 million USD |
| 2019 | -20.7 million USD | 6.8 million USD |
VACC
Price: $5
52 week price:
Earnings Per Share: -1.87 USD
P/E Ratio: 15.64
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 171964
Market Capitalization: 192.7 million